1. Home
  2. MIST vs NVEC Comparison

MIST vs NVEC Comparison

Compare MIST & NVEC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MIST
  • NVEC
  • Stock Information
  • Founded
  • MIST 2003
  • NVEC 1989
  • Country
  • MIST Canada
  • NVEC United States
  • Employees
  • MIST N/A
  • NVEC N/A
  • Industry
  • MIST Biotechnology: Pharmaceutical Preparations
  • NVEC Semiconductors
  • Sector
  • MIST Health Care
  • NVEC Technology
  • Exchange
  • MIST Nasdaq
  • NVEC Nasdaq
  • Market Cap
  • MIST 53.9M
  • NVEC 282.2M
  • IPO Year
  • MIST N/A
  • NVEC 1996
  • Fundamental
  • Price
  • MIST $1.11
  • NVEC $67.64
  • Analyst Decision
  • MIST Strong Buy
  • NVEC
  • Analyst Count
  • MIST 2
  • NVEC 0
  • Target Price
  • MIST $9.50
  • NVEC N/A
  • AVG Volume (30 Days)
  • MIST 1.6M
  • NVEC 21.4K
  • Earning Date
  • MIST 05-20-2025
  • NVEC 05-07-2025
  • Dividend Yield
  • MIST N/A
  • NVEC 5.92%
  • EPS Growth
  • MIST N/A
  • NVEC N/A
  • EPS
  • MIST N/A
  • NVEC 3.11
  • Revenue
  • MIST N/A
  • NVEC $25,874,694.00
  • Revenue This Year
  • MIST N/A
  • NVEC N/A
  • Revenue Next Year
  • MIST N/A
  • NVEC N/A
  • P/E Ratio
  • MIST N/A
  • NVEC $21.72
  • Revenue Growth
  • MIST N/A
  • NVEC N/A
  • 52 Week Low
  • MIST $0.63
  • NVEC $51.50
  • 52 Week High
  • MIST $2.75
  • NVEC $89.98
  • Technical
  • Relative Strength Index (RSI)
  • MIST 43.96
  • NVEC 68.10
  • Support Level
  • MIST $1.28
  • NVEC $60.29
  • Resistance Level
  • MIST $1.32
  • NVEC $69.91
  • Average True Range (ATR)
  • MIST 0.12
  • NVEC 2.15
  • MACD
  • MIST 0.02
  • NVEC 1.32
  • Stochastic Oscillator
  • MIST 27.39
  • NVEC 83.39

About MIST Milestone Pharmaceuticals Inc.

Milestone Pharmaceuticals Inc is a biopharmaceutical company dedicated to developing and commercializing etripamil for the treatment of cardiovascular medicines. Etripamil is a calcium channel blocker developed as a rapid-onset nasal spray to be administered by the patient to treat episodes of paroxysmal supraventricular tachycardia, or PSVT. The company has an ongoing Phase 2 clinical trial for patients with atrial fibrillation experiencing a rapid ventricular rate (AFib-RVR).

About NVEC NVE Corporation

NVE Corp develops and sells devices that use spintronics, a nanotechnology that relies on electron spin. It manufactures high-performance spintronic products including sensors and couplers that are used to acquire and transmit data. The company's products include Digital sensors, Medical sensors, Rotation Sensors, GT Sensors, Angle Sensors, Analog sensors, MSOP Isolators, Passive-In Transceivers, and others. The company manufactures high-performance spintronic products including sensors and couplers. The company's designs are based on giant magnetoresistance GMR and tunneling magnetoresistance TMR combined with integrated circuitry.

Share on Social Networks: